日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

系统性硬化症的生物学特征存在于系统性硬化症早期诊断(VEDOSS)患者的皮肤和血清中。

Ross, Rebecca L; Caballero-Ruiz, Begoña; Clarke, Emily L; Kakkar, Vishal; Wasson, Christopher W; Mulipa, Panji; De Lorenzis, Enrico; Merchant, Will; Di Donato, Stefano; Rindone, Andrea; Herrick, Ariane L; Denton, Christopher P; Riobo-Del Galdo, Natalia A; Del Galdo, Francesco

Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses

SARS-CoV-2疫苗在接受DMARDs治疗的类风湿性关节炎(RA)患者中的有效性:通过抗体和T细胞反应测定

Saleem, Benazir; Ross, Rebecca L; Bissell, Lesley-Anne; Aslam, Aamir; Mankia, Kulveer; Duquenne, Laurence; Corsadden, Diane; Carter, Clive; Hughes, Pam; Nadat, Fatima A; Mulipa, Panji; Lobb, Mark; Clarke, Brendan; Mbara, Katie; Morton, Ruth; Dibb, Sophie; Chowdhury, Rahaymin; Newton, Darren; Pike, Alexandra; Kakkar, Vishal; Savic, Sinisia; DelGaldo, Francesco; Emery, Paul

Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis

Dersimelagon 是一种新型口服黑皮质素 1 受体激动剂,在系统性硬化症的临床前模型中表现出改善病情的作用

Masahiro Kondo, Tsuyoshi Suzuki, Yuko Kawano, Shinji Kojima, Masahiko Miyashiro, Atsuhiro Matsumoto, Gabriela Kania, Przemysław Błyszczuk, Rebecca L Ross, Panji Mulipa, Francesco Del Galdo, Yun Zhang, Jörg H W Distler

SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker.

SFRP4 表达与免疫驱动的纤维化疾病相关,与系统性硬化症的皮肤和肺纤维化相关,并且是潜在的 EMT 生物标志物

Tinazzi Ilaria, Mulipa Panji, Colato Chiara, Abignano Giuseppina, Ballarin Andrea, Biasi Domenico, Emery Paul, Ross Rebecca L, Del Galdo Francesco